Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Epizyme Strengthens Leadership Team with...||07/22/19|
|Mr. Tombesi brings over 30 years of extensive financial and accounting expertise to Epizyme, most recently serving as the chief financial officer at I...|
|Here's Why Epizyme Rose 103.7% in t...||07/12/19|
|The company put a clinical hold from 2018 behind it and submitted its first-ever new drug application.|
|Date||2019-05-06 (BMO)||Est. (EPS/Rev.)||($0.46)/ 2.16M|
|Actual (EPS/Rev.)||$-0.39/ $7.89 M||EPS (TTM)||0|